A structural gap in temperature-controlled logistics across Sub-Saharan Africa is creating a commercially viable niche for mid-market logistics firms. While multinational operators and large third-party logistics providers concentrate on capital-city hubs and primary ports, secondary cities — those with populations between 500,000 and 3 million — remain underserved for cold chain storage of pharmaceuticals and perishable food. This imbalance is not a temporary disruption. It reflects a persistent mismatch between infrastructure investment and demographic reality.
The Nature of the Gap
Cold chain capacity in Sub-Saharan Africa is heavily concentrated. According to industry estimates cited by the Global Cold Chain Alliance, the region has roughly 30 million cubic metres of temperature-controlled storage, but more than 70 per cent of that capacity sits in South Africa, Nigeria and Kenya, predominantly in and around Johannesburg, Lagos and Nairobi. Secondary cities such as Kumasi (Ghana), Mombasa (Kenya), Douala (Cameroon), Lusaka (Zambia) and Maputo (Mozambique) have significantly less purpose-built cold storage relative to their population and economic activity.
This concentration creates a logistics bottleneck. Pharmaceuticals requiring strict temperature control — vaccines, insulin, biologics — often must be shipped from primary hubs to secondary cities via general freight, risking temperature excursions. Perishable food producers in secondary regions face similar constraints: they either absorb high spoilage rates or pay a premium to truck products long distances to centralised cold stores.
Why Mid-Market Firms Are Moving In
Mid-market logistics firms — typically those with annual revenues between $10 million and $200 million — are better positioned than either large multinationals or local owner-operators to exploit this gap. Large operators face high overheads and require minimum throughput volumes that secondary cities do not yet guarantee. Local operators often lack the capital, technical expertise and certification (such as WHO Good Distribution Practices for pharmaceuticals) to build and operate compliant cold storage.
Mid-market firms can deploy modular, containerised cold storage units that cost between $50,000 and $150,000 per unit, depending on size and specification. These units can be installed on existing warehouse sites, reducing land acquisition costs. Several firms in East and West Africa have begun offering temperature-controlled storage as a service, charging per pallet per day or per cubic metre per month, with typical margins of 25 to 35 per cent on the storage element alone, according to operator disclosures reviewed by The FY Times.
Commercial Impact
The commercial logic is straightforward. Pharmaceutical distributors in secondary cities currently pay a premium of 15 to 25 per cent above primary-city cold storage rates, reflecting scarcity and transport risk. By building local capacity, mid-market firms can undercut that premium while still earning healthy margins. For perishable food exporters — such as avocado growers in Kenya or mango producers in Ghana — local cold storage reduces post-harvest losses, which the African Development Bank estimates at 30 to 40 per cent for fresh produce. Even a modest reduction in spoilage translates directly into improved margins for producers and logistics providers alike.
Revenue models vary. Some firms charge a flat monthly fee for dedicated storage space. Others offer a variable model based on throughput, with additional fees for inventory management, order picking and last-mile delivery. The most successful operators bundle storage with transport, offering a door-to-door cold chain service that commands a 10 to 15 per cent premium over standalone storage or transport.
Why It Matters
For founders and operators in logistics, the cold chain gap in secondary African cities represents a repeatable, capital-efficient expansion opportunity. It does not require building a national network from scratch. A single temperature-controlled facility in a well-chosen secondary city can serve a regional catchment area of several million people and multiple industries. For investors, the asset class — cold storage infrastructure — offers tangible collateral value and long-term demand visibility driven by population growth, urbanisation and expanding pharmaceutical distribution.
For executives in pharmaceutical and food companies, the development of local cold chain capacity reduces supply chain risk and improves product quality. It also opens the possibility of sourcing perishable goods from regions previously considered too remote or too risky.
Risks and Unknowns
Several risks warrant caution. Power reliability remains a significant operational risk in many secondary cities. Backup generators and solar-battery systems add capital cost and require ongoing maintenance. Regulatory compliance for pharmaceutical storage is non-trivial: temperature mapping, validation and audit readiness demand specialised expertise that may be scarce locally.
Demand forecasting is another uncertainty. While the gap is real, the pace at which pharmaceutical and perishable volumes grow in a given secondary city depends on factors such as local economic development, healthcare infrastructure investment and export market access. Overbuilding capacity ahead of demand would erode margins.
Currency risk is material for firms operating across multiple African markets. Revenue is often earned in local currency, while equipment and some inputs are priced in dollars or euros. Hedging options are limited for mid-market firms.
FY Outlook
Over the next 24 to 36 months, The FY Times expects to see a wave of mid-market cold chain investments in secondary cities across East and West Africa, particularly in countries with stable regulatory environments and growing pharmaceutical distribution networks. Ghana, Kenya, Côte d’Ivoire and Zambia are likely early markets. The entry of regional logistics firms into this space will put downward pressure on cold storage pricing in secondary cities, compressing margins for early movers but expanding the total addressable market.
Consolidation is probable. Firms that build a network of three to five facilities across multiple secondary cities will be attractive acquisition targets for larger logistics groups seeking to expand their African cold chain footprint without the cost of greenfield development.
Conclusion
The Sub-Saharan cold chain gap is not a speculative opportunity. It is a measurable, underserved market segment with clear demand drivers and a viable business model. Mid-market logistics firms that move early, invest in compliance and manage operational risks carefully can capture significant margin. The window of first-mover advantage is likely to last two to three years before competition intensifies and pricing normalises. For commercially curious readers, this is a sector worth monitoring closely.
